We are looking for child to join a research to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or moderately to severely active ulcerative colitis (including associated symptoms such as joint pain, loss of appetite, bloody stool, chronic fatigue and/or anemia), consider one of our GI clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your child may be eligible to take part.
Your child may be eligible to take part in the GI clinical trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrolling for a limited time.
